ANTI-DESTRUCTIVE EFFECT OF RITUXIMAB AND B-CELL COUNT IN RHEUMATOID ARTHRITIS PATIENTS

被引:0
|
作者
Pivanova, Anastasia V. [1 ]
Lukina, Galina V. [1 ]
Sigidin, Yakov A. [1 ]
Smirnov, Aleksandr V. [1 ]
Kuzikyants, Kristina Kh [1 ]
Kuznetsova, Anna Yu [1 ]
Nasonov, Evgeni L. [1 ]
机构
[1] VA Nasonova Res Inst Rheumatol, Moscow, Russia
关键词
D O I
10.1136/annrheumdis-2016-211055.50
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
08.50
引用
收藏
页码:A97 / A97
页数:1
相关论文
共 50 条
  • [21] Impaired early B-cell tolerance in patients with rheumatoid arthritis
    Samuels, J.
    Ng, Y-S
    Paget, D.
    Meffre, E.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S30 - S31
  • [22] Impaired early B-cell tolerance in patients with rheumatoid arthritis
    J Samuels
    Y-S Ng
    D Paget
    E Meffre
    [J]. Arthritis Research & Therapy, 7
  • [23] THE BLOOD B-CELL SUBSETS AND EFFECT OF TOCILIZUMAB THERAPY ON THEM IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Gerasimova, E.
    Popkova, T.
    Aleksankin, A.
    Davidyan, S.
    Martinova, A.
    Aleksandrova, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 950 - 951
  • [24] B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
    Shaw, T
    Quan, J
    Totoritis, MC
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 55 - 59
  • [25] Effect of B CELL depletion by Rituximab in T cell subpopupulations from the peripheral blood of patients with rheumatoid arthritis
    Lopez-Lopez, J.
    Alfonso-Perez, M.
    Castaneda, S.
    Alvaro-Gracia, J. M.
    Velasco, T.
    Vega Piris, L.
    Rodriguez Salvanes, F.
    Lopez Huete, V.
    Ramirez Mengibar, A.
    Garcia-Vicuna, R.
    Gonzalez-Alvaro, I.
    Munoz-Calleja, C.
    [J]. IMMUNOLOGY, 2012, 137 : 576 - 576
  • [26] Rituximab in the treatment of B cell lymphoma in rheumatoid arthritis
    O'Callaghan, Ailish
    Summerfield, Geoff
    Hendrick, Alex
    Heycock, Carol
    Hamilton, Jennifer
    Saravanan, Vadivelu
    Kelly, Clive A.
    [J]. RHEUMATOLOGY, 2008, 47 : II106 - II106
  • [27] Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
    Edwards, JCW
    Szczepanski, L
    Szechinski, J
    Filipowicz-Sosnowska, A
    Emery, P
    Close, DR
    Stevens, RM
    Shaw, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25): : 2572 - 2581
  • [28] Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis
    Ramwadhdoebe, Tamara H.
    van Baarsen, Lisa G. M.
    Boumans, Maria J. H.
    Bruijnen, Stefan T. G.
    Safy, Mary
    Berger, Ferco H.
    Semmelink, Johanna F.
    van der Laken, Conny J.
    Gerlag, Danielle M.
    Thurlings, Rogier M.
    Tak, Paul P.
    [J]. RHEUMATOLOGY, 2019, 58 (06) : 1075 - 1085
  • [29] The Effect of Anti-B-cell Therapy on the Development of Atherosclerosis in Patients with Rheumatoid Arthritis
    Novikova, Diana S.
    Popkova, Tatyana V.
    Nasonov, Eugeny L.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (11) : 1512 - 1518
  • [30] SERUM RITUXIMAB LEVELS AND EFFICIENCY OF B-CELL DEPLETION: DIFFERENCES BETWEEN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
    Reddy, Venkat
    Croca, Sara
    Gerona, Delia
    De La Torre Ortega, Inmaculada
    Isenberg, David A.
    Leandro, Maria
    Cambridge, Geraldine
    [J]. RHEUMATOLOGY, 2013, 52 : 132 - 132